Loring Wolcott & Coolidge Fiduciary Advisors’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-83
Closed -$5K 609
2016
Q2
$5K Hold
83
﹤0.01% 589
2016
Q1
$5K Hold
83
﹤0.01% 573
2015
Q4
$20K Hold
83
﹤0.01% 512
2015
Q3
$32K Hold
83
﹤0.01% 461
2015
Q2
$32K Buy
+83
New +$32K ﹤0.01% 461